Skip to main content

Security report for novonordisk.cz

Novo Nordisk, s.r.o. · Healthcare · Czech Republic

Low risk. 1 critical or high finding in Security headers.

Security score

81/100

Risk levelLow

0–100, higher is better. How it is calculated

Novo Nordisk, s.r.o. is a well-established healthcare company specializing in diabetes care, obesity, growth disorders, and hemophilia treatments. The company has a strong market position as a global leader in these therapeutic areas, supported by a comprehensive website that provides detailed information about its heritage, products, and career opportunities. The website targets healthcare professionals, patients, and potential employees, reflecting a mature business model focused on pharmaceutical manufacturing and healthcare services. The company is part of the larger Novo Nordisk A/S group, founded in 1923, indicating a long-standing presence in the industry. Technically, the website leverages modern technologies including Adobe Experience Manager CMS, Vue.js framework, and Adobe's analytics and tag management tools. It is well-optimized for mobile devices and accessibility, with good SEO practices and a moderate performance profile. The site implements a robust cookie consent mechanism via OneTrust, ensuring compliance with GDPR and other privacy regulations. From a security perspective, the site enforces HTTPS and uses cookie consent to manage user privacy. However, it lacks visible security headers and a published security policy or incident response information, which are areas for improvement. No vulnerabilities or exposed sensitive data were detected in the content. The absence of WHOIS data limits the ability to fully verify domain legitimacy, but the professional presentation and comprehensive contact information support the site's credibility. Overall, the website demonstrates a strong digital presence with good content quality, technical implementation, and privacy compliance. Strategic recommendations include enhancing security headers, publishing security policies, and verifying domain registration details to strengthen trust and security posture.

Scanned

NIS2 and GDPR posture

GDPR outside view
83/ 100 · Low
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

1 finding rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

Need hands-on remediation? Email guard@offseq.com

Keep watching novonordisk.cz

This scan found 16 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
95
Security headers
65
Email security
60
DNS health
85
Network security
100
GDPR outside view
83
Average
81

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Breach exposure

Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.

Dark web exposure

Add-on

Leaked records that mention novonordisk.cz, from OffSeq Breach.

No leaked records found

Breach holds no records for novonordisk.cz right now. New leaks arrive continuously, so monitoring on Breach alerts you if that changes.

Monitor on Breach (opens in a new tab)

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Novo Nordisk operates in the healthcare sector with a focus on chronic diseases such as diabetes and obesity. The company benefits from a strong brand and global recognition, supported by a detailed and localized Czech website. Its business model centers on pharmaceutical product development and patient support services. The company actively recruits talent worldwide, indicating growth and investment in human capital. The presence of compliance hotlines and whistleblowing links reflects a mature governance framework. Partnerships with career platforms and adherence to privacy regulations demonstrate a well-integrated digital ecosystem. Market positioning is strong, leveraging decades of heritage and scientific expertise. The company’s operations are transparent, with clear communication channels and social media engagement, enhancing stakeholder trust.

Security posture

The website exhibits a moderate to good security posture with HTTPS enforced and a comprehensive cookie consent mechanism that aligns with GDPR requirements. The use of Adobe DTM and OneTrust indicates attention to privacy and data protection. However, the absence of key security headers such as Content-Security-Policy, X-Frame-Options, and X-XSS-Protection reduces the overall security robustness. No security.txt or vulnerability disclosure pages were found, limiting transparency in incident response readiness. The site does not expose sensitive data or use vulnerable libraries in the visible content. Recommendations include implementing missing security headers, publishing security policies, and establishing a vulnerability disclosure program to enhance security maturity and stakeholder confidence.

Recommendations

  1. Implement comprehensive security headers including Content-Security-Policy, X-Frame-Options, and X-XSS-Protection.
  2. Publish a clear security policy and incident response information on the website.
  3. Establish and publicize a vulnerability disclosure program or security.txt file.
  4. Regularly audit and update third-party scripts and libraries to mitigate vulnerabilities.
  5. Enhance domain registration transparency by ensuring WHOIS data is publicly available and accurate.

Contact details published on the site

Addresses
Legal name
Novo Nordisk, s.r.o.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Novo Nordisk, s.r.o.
Description
Novo Nordisk is a healthcare company committed to improving health since 1923, focusing on diabetes, obesity, growth disorders, and hemophilia.
Key services
Pharmaceutical products for diabetes, Obesity treatment, Growth disorder therapies, Hemophilia treatment, Career opportunities
Content quality
good
Branding
consistent

Technology

Stack
Adobe Helix RUM, Vue.js, OneTrust Cookie Consent, Adobe DTM (Dynamic Tag Management), jQuery, Typekit Fonts
Frameworks
Vue.js
Performance
moderate
Mobile
good
Accessibility
good
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Cookie consent mechanism implemented
  • No exposed sensitive data in HTML

Analytics and tracking

Services
Adobe Analytics
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
Adobe Analytics
Marketing tools
Adobe DTM, OneTrust Cookie Consent
Transparency
good

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with rich content in Czech language.
  2. Strong focus on healthcare and pharmaceutical industry.
  3. Comprehensive cookie consent and privacy policy in place.
  4. Multiple contact channels including email, phone, and contact form.
  5. No visible security policy or incident response information.
  6. WHOIS data unavailable, limiting domain trust verification.
  7. Use of modern web technologies and Adobe Experience Manager CMS.
  8. Social media presence across major platforms.
  9. No signs of adult or inappropriate content.
Technical notes

Notes

The website is built on Adobe Experience Manager CMS with Vue.js components, indicating a modern and scalable infrastructure. It uses Adobe's analytics and tag management tools for data collection and marketing optimization. The site loads scripts asynchronously to improve performance and includes mobile optimization and accessibility features. The presence of OneTrust for cookie consent shows compliance with privacy regulations. Performance is moderate, with room for optimization in loading times and resource management. The technical stack is robust but could benefit from enhanced security configurations and regular maintenance of third-party dependencies to reduce technical debt and security risks.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with novonordisk.cz. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review novonordisk.cz.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.